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Abstract: 
Treatments of diabetes with available agents comes with one or more side effects, hence, there is need for 
continual search of alternative treatment agents from medicinal plants. This study was designed to evaluate 
the antioxidant property and hypolipidaemic effect of Phyllanthus fraternus methanolic leaf extract in 
diabetic rats. The antioxidant property was evaluated using DPPH free radical scavenging activity and ferric 
reducing antioxidant power (FRAP) assay. Thirty rats were used out of which twenty four were diabetic. 
Diabetes was induced by administration of streptozotocin (STZ) intraperitoneally at 60 mg/kg body weight 
(bw). Five experimental groups (Group A-E) of six rats each were used, the treatment lasted for 28 days; 
group A was normal control, B was diabetic control while C was standard control treated with metformin at 
5mg/kg bw., group D and E received (200 and 300) mg/kg bw of the extract respectively. The IC50 for free 
radical scavenging activity of P. fraternus and ascorbic acid were 43.98 mg/ml and 47.04 mg/ml 
respectively, while that of ferric reducing antioxidant power (FRAP) were 48.17mg/ml and 51.95mg/ml for 
P.fraternus and ascorbic acid respectively. Treatments with different doses of methanolic leaf extract of 
Phyllanthus fraternus and metformin were shown to significantly (p<0.05) decrease the hyperlipidemia 
observed in the diabetic control group. Similarly, the level of HDL was observed to be significantly (p<0.05) 
higher in all the treatment groups when compared to the diabetic untreated group. The reversal of 
abnormalities observed in lipid profile by methanolic extract of P. fraternus and its antioxidant potency 
offered a potential source of new orally active agent that can halt and reverse most complications due to 
diabetes.  
Key words:  Antioxidant, hypolipidaemia, Streptozotocin,  Phyllanthus fraternus, extract 
Corresponding Author: 
Nadro, M.S, 
Department of Biochemistry, 
Gombe state University, Gombe. Nigeria. 
Email: msnadro@yahoo.com 
 
 
 
Please cite this article in press as Nadro, M.S.  and Elkanah, G, Antioxidant and Hypolipidaemic Effects of 
Phyllanthus Fraternus Methanolic Leaf Extract on Streptozotocin- Induced Diabetic Rats, Indo Am. J. P. 
Sci, 2017; 4(01). 
QR code 
 
IAJPS 2017, 4 (01), 103-109             Nadro, M.S and Elkanah, G.          ISSN 2349-7750 
 
w w w . i a j p s . c o m  
 
Page 2 
INTRODUCTION: 
Diabetes mellitus is described by world health 
organization (WHO) as a group of metabolic 
diseases in which there are high blood sugar 
levels over a prolonged period (WHO, 2014) [1]. 
This prolonged high blood sugar levels arises 
either because insulin production is insufficient, 
or because the body’s cell do not respond 
properly to insulin, or both. Patients with high 
blood sugar will typically experience frequent 
urination (polyuria), increasingly thirsty 
(polydipsia) and distinctly hungry (polyphagia)  
[2] .  
Diabetes can cause many complications if left 
untreated (WHO, 2013) [3]. Acute complications 
include diabetic ketoacidosis and non ketotic 
hyperosmolar coma [4]. Serious long-term 
complications include cardiovascular disease, 
stroke, kidney failure, foot ulcers and damage to 
the eyes (WHO, 2013). Management concentrates 
on keeping blood sugar levels as close to normal 
("euglycemia") as possible, without causing 
hypoglycemia. This can usually be accomplished 
with a healthful diet, exercise, and use of 
appropriate medications (insulin in the case of 
type 1 diabetes; oral medications, as well as 
possibly insulin, in type 2 diabetes). In spite of 
these advances and effort made towards treating, 
managing, and perhaps preventing the health, 
economic and social effects of diabetes mellitus, 
the prevalence of the disease globally is on the 
increase. As of 2014, an estimated 387 million 
people have diabetes worldwide as contained in 
the report of International Diabetes Federation 
(IDF, 2014), with type 2 diabetes making up 
about 90% of the cases. This is equal to 8.3% of 
the adult population, with equal rates in both 
women and men [5]. In the years 2012 to 2014, 
diabetes was estimated to have resulted in 1.5 to 
4.9 million deaths per year respectively (WHO, 
2013, IDF, 2014)[1,3].  The number of people 
with diabetes is expected to rise to 592 million by 
2035 (IDF, 2014) [6]. The global economic cost 
of diabetes in 2014 was estimated to be $612 
billion USD (IDF, 2013) [7]. Hence, there is an 
urgent need for new therapeutic drug with high 
efficacy, low cost, little or no side effects and 
wider availability if this trend must be reversed. 
Many plants have been studied in search for 
antidiabetic activity, some components isolated, 
but with respect to Phyllanthus fraternus, there 
has been little scientific record to support its anti 
diabetic activity and to some extent, its active 
components. 
Free radical-scavenging ability of antioxidants 
may reduce the oxidative stress and thus may 
protect against oxidative damage [8]. Based on 
observational studies among healthy individuals, 
antioxidant concentrations were found to be 
inversely correlated with several biomarkers of 
insulin resistance or glucose intolerance[9,10].  
Antioxidants may induce beneficial effects on 
diabetic complications by reducing blood 
pressure, attenuating oxidative stress and 
inflammatory biomarkers, improving lipid 
metabolism and insulin-mediated glucose 
disposal, as well as by enhancing endothelial 
function.  [10,11, 12]. 
 Phyllanthus fraternus  belongs to the family 
Euphorbiaceae,  it is commonly called; gulf leaf 
flower, Chanca piedra, quebra pedra, stone 
braker, arranca-pedras, carry-me-seed, hurricane 
weed, paraparai mi, quinine weed (Matur et al., 
2009). The plant has been employed for numerous 
uses such as treatment of blennorrhagia, colic, 
diabetes, dysentery, fever, flu, tumors, jaundice, 
vaginitis and dyspepsia. It is also used as a 
laxative, stomachic, tonic and vermifuge [13].  It 
has been used for as folk medicine in the 
treatment of liver, kidney and bladder problem 
and intestinal parasites [14]. Particularly 
Phyllanthus fraternus herb is bitter in taste and 
reported to possess diuretic, hypotensive, 
hypoglycemic effect, antihyperlipemic, 
antihepatotoxic and anti oxidant activity [15]. An 
aqueous extract of the leaves lowers blood sugar 
level in normal and alloxan diabetic rabbits[16]. 
Different fractions of alcoholic extracts of aerial 
parts and root of  Phyllanthus fraternus were 
screened for antihepatotoxic activity on carbon 
tetrachioride (CCL4) induced liver damage [17].  
 
The aim of this study is to evaluate the In vitro 
antioxidant property and hypolipidaemic effect of  
Phyllanthus fraternus methanolic leaf extract on 
streptozotocin induced diabetic rats.  
 
MATERIALS AND METHOD: 
Plant material 
The plant material of Phyllanthus fraternus 
Webster (Leaves) was collected in the month of 
May, around 6am at Hayin gada, in Girei local 
Government area of Adamawa State which lies on 
geographical location 9° 21’53.19’’North and 12° 
33’28.33’’East Google earth (2014). It was 
authenticated by a botanist in the Department of 
Biological Sciences, Modibbo Adama University 
of Technology, Yola, Adamawa State.  
Experimental animals   
Male albino rats (5 - 6 weeks) weighing 100 – 
130 g numbering 30 were obtained from 
Veterinary Research Institute VOM, Jos, Plateau 
State and kept in plastic cages with 12 h dark/light 
cycle,  fed with pelletized grower diet (Vital 
Feeds, UACN) and given water ad libitum.  
 
Equipments      
The following equipments were used; Electronic 
balance (Golden mettle-2G2-USA), ACCU-
CHEK Glucometer (GC-Roche Diagnostic-
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Germany) , ACCU-CHEK Test Strips (Roche 
Diagnostic-Germany), Spectrophotometer (Vis 
spectrophotometer 721- PEC Medical USA),  
Centrifuge (Techmel, USA), Water bath (HH-2 
B-Scientific). 
 
Chemicals     
Methanol (Sigma-Aldrich Chemie GMbH, 
Germany), Streptozotocin (Tocris Bioscience 
London), Metformin, Chloroform, Total 
Cholesterol (TC), High Density Lipoprotein 
(HDL) and Triglycerides (TG) (AGAPPE 
Diagnostic kits, Switziland). All other chemicals 
used were of analytical grade. 
 
Methods 
Preparation of plant material                                                                               
   
The fresh plant material (leaf) was washed with 
tap water and shade dried for seven days. It was 
made into powder using mortar and pestle. The 
powdered plant material was used for the 
preparation of methanolic extract. 
 
Preparation of methanolic extract 
Methanolic extract was prepared by suspending 
200 g of the powdered sample in 2 L of methanol 
for 24 hours with vigorous shaken intermittently, 
after which it was filtered and then concentrated 
at 55 oC using a water bath [18]. 
 
Determination of in vitro antioxidant properties 
DPPH (2, 2-diphenyl-l-picryl hydrazyl) radical 
scavenging assay    
The  antioxidant  activity  of  the  plant  extracts  
was  estimated  using  the  DPPH radical 
scavenging protocol. DPPH solution (0.004% 
w/v) was prepared in 95% ethanol. A stock 
solution of methanolic leaf extract of Phyllanthus 
fraternus (MLEP) and standard ascorbic acid 
were prepared in the concentration of 1 g/100 ml 
(10 mg/ml). From stock solution 2 ml, 4 ml, 6 ml, 
8 ml & 10 ml of this solution were taken in five 
test tubes respectively. The final volume of each 
test tube was made up to 10 ml with distill water, 
given a concentration of 20 mg/ml, 40 mg/ml, 60 
mg/ml, 80 mg /ml & 100 mg/ml respectively. 2 
ml of freshly prepared DPPH solution (0.004% 
w/v) was added in each of the tubes.   The 
reaction mixture was incubated in the dark for 15 
min and thereafter the optical density was 
recorded at 523 nm against the blank. For the 
control, 2 ml of DPPH solution in ethanol was 
mixed with 10 ml of ethanol and the optical 
density of the solution was recorded after 30 min. 
The test was carried out in triplicates. The 
decrease in optical density of DPPH on addition 
of test samples in relation to the control was used 
to calculate the antioxidant activity, as percentage 
inhibition (%IP) of DPPH radical. The capability 
of scavenging DPPH radical was calculated using 
the following equation[19,20,21].  
 
DPPH Scavenged (%) =   x 100  
                        
Where “A control” is the absorbance of the 
control reaction and “A test” is the absorbance of 
the sample of the extracts. IC 50 values denote the 
concentration of sample, which is required to 
scavenge 50% of DPPH free radicals. 
 
Ferric reducing antioxidant power (FRAP) 
assay 
In ferric reducing antioxidant power assay, 1 ml 
of test sample of methanolic leaf extract of 
Phyllanthus fraternus (MLEP) in different 
concentration were mixed with 1 ml of 0.2 M 
sodium phosphate buffer (pH 6.6) and 1 ml of 1% 
potassium ferricyanide in separate test tubes. The 
reaction mixtures were incubated in a 
temperature-controlled water bath at 50 0C for 20 
min, followed by addition of 1 ml of 10% 
trichloroacetic acid. The mixtures were then 
centrifuged for 10 min at room temperature. The 
supernatant obtained (1 ml) was added with 1 ml 
of distilled water and 0.20 ml of 0.1% FeCl3. The 
blank was prepared in the same manner as the 
sample except that 1% potassium ferricyanide 
was replaced  by distilled water. The absorbance 
of the reaction mixture was measured at 700 nm. 
The reducing power was expressed as an increase 
in A700 after blank subtraction[22].  
 
 
Induction of diabetes mellitus in rats 
All the rats were fasted overnight before the 
administration of Streptozotocin. Diabetes was 
induced in rats by intra-peritoneal injection of 
streptozotocin dissolved in distilled water at a 
dose of 60mg/kg body weight [23]. After the 
injection, the rats were allowed free access to 
food and water. To prevent fatal hypoglycaemia 
due to massive pancreatic insulin release, rats 
were given 5% glucose solution water in their 
cages for next 24 h [24]. 
 
The animals were tested after 72 hours of 
streptozotocin administration. The animals with 
fasting blood glucose more than 300mg/dl were 
considered diabetic and were used for the 
experiment [25,26].  
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Figure 1: Induction of Diabetes by Intraperitoneal Injection of Streptozotocin (60mg/kgbw) in Albino 
Rats 
 
Keys 
BI= before induction 
DAI=Days after induction 
 
Experimental Design 
In this experiment, a total of 30 rats were used (24 diabetic and, 6 normal). The rats were divided into five 
groups of six rats each; the grouping/ treatment given are shown below; 
 
All the animals were allowed free access to food 
and water ad libitum. The treatment lasted for 
28days. At the end of the treatment, rats were 
anaesthetized by placing them in a sealed jar with 
cotton wool soaked in chloroform. Blood was 
collected via cardiac puncture from each animal 
in a plane bottle. The bloods collected were 
labelled accordingly and were centrifuged at 3000 
revolution per minute (rpm) for five minutes to 
separate the serum from plasma. The serum were 
carefully collected and transferred to new plane 
bottles which were subsequently used for 
biochemical analysis. 
 
Determination of cholesterol 
Total Cholesterol and High Density Lipoprotein 
(HDL) was determined by methods as described 
by Allain et al., (1974) [27].  
 
Determination of triacylglycerides 
The triglycerides were determined as described by 
Jacobs and VanDemark, (1960) [28]. 
 
Statistical Analysis: 
Values obtained were expressed as mean ± SEM 
and data were analysed using analysis of variance 
(ANOVA) with Bonferroni Post hoc test multiple 
comparison versus control groups with help of 
Statistical Package for the Social Sciences (SPSS) 
software version 21. The values p< 0.05 were 
considered significant[29].  
 
 
 
Group                                                                                                  Treatment 
Group -A (Normal Control)                                                Normal + no treatment 
Group- B (Negative control)                                              Diabetic + no treatment 
Group-C (Positive control)                                                 Metformin 5 mg/kg-1 
Group-D                                                                             Extract 200 mg/kg b.w 
Group-E                                                                              Extract 300 mg/kg b.w 
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RESULTS: 
 
Table 1; DPPH radical scavenging activity of Phyllanthus fraternus and Ascorbic acid 
                                     Phyllanthus fraternus                L. Ascorbic acid 
         Conc (mg/ml)    % Inhibition             IC50                           % Inhibition              IC50 
20                    53.10 ± 0.01                                       50.04 ± 0.22 
40                    72.32 ± 0.40                                       69.23 ± 0.05 
60                    78.34 ± 0.32        43.98 mg/ml           79.49 ± 0.22        47.04 mg/ml 
80                    88.80 ± 0.04  ⃰                                     81.40 ± 0.02 
100                  92.53 ± 0.26  ⃰                                     83.30 ± 0.44 
 
Values are mean ± SEM (n=3),   ⃰ significantly higher than L. Ascorbic acid at p<0.05. The IC50 
was obtained by linear regression equation.  
 
 
 
 
Figure 1: Ferric Reducing Antioxidant Power (FRAP) of Methanolic Leaf extract of P. fraternus and 
Ascorbic Acid 
⃰ Significantly higher compared with L. Ascorbic acid at p<0.05 
IC 50 for P. fraternus = 48.17 
IC 50 for L. Ascorbic acid = 51.95 
Ferric reducing antioxidant power (FRAP) of 
methanolic leaf extract of P.  fraternus 
The reducing antioxidant power of the methanolic 
leaf extract of P. fraternus (Figure 1) showed a 
linear increase in the reducing power across a 
concentration range of 20-100 mg/ml of the 
extract and ascorbic acid. The reducing power of 
methanolic leaf extract of P. fraternus was 
significantly (p<0.05) higher than that of ascorbic 
acid at concentrations of 20, 40 and 60 mg/ml.  
 
Effects of Methanolic Leaf Extract of 
Phyllanthus fraternus on Lipid Profile in 
Streptozotocin Induced Diabetic rats 
The study revealed (Table 2) an increase in serum 
total cholesterol (TC), triacylglycerides (TG) and 
low density lipoprotein (LDL) with decrease in 
high density lipoprotein (HDL) in the diabetic 
untreated group when compared with the normal 
control. Treatments with different doses of 
methanolic leaf extract of Phyllanthus fraternus 
and metformin were shown to significantly 
(p<0.05) decrease the hyperlipidemia observed in 
the diabetic control group. The low level of HDL 
observed in diabetic control group was shown to 
significantly (p<0.05) increase in all the treatment 
groups when   compared to the diabetic untreated 
groups. 
* * 
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Table 2: Effects of Methanolic Leaf Extract of Phyllanthus Fraternus on Lipid Profile (mg/dl) in 
Streptozotocin Induced Diabetic Rats 
Treatment                        TC                        TG                    HDL                     LDL                                 
 Normal Control        160.74 ± 1.83       77.33 ± 1.76               45.00 ± 1.73            100.27 ± 0.89   
Diabetic Control       240.33 ± 1.45a          184.00 ± 2.08a      17.66 ± 0.88          185.87 ± 0.92a      
Met.5mg/kg-b.w.     188.33 ± 0.88ab       88.00 ± 1.15ab     36.66 ± 0.88c          133.74 ± 0.61ab 
ME 200mg/kg b.w.   194.00 ± 2.08ab      94.00 ± 1.52ab     28.00 ± 0.57c         147.20 ± .18ab 
ME 300mg/kg b.w.   183.33 ± 1.76ab         89.66 ± 0.88ab     30.00 ± 1.15cd        135.39 ± 0.31ab 
Values are mean ± SEM; n=5. 
Different letter(s) superscript along the same column means there is significant difference at p˂0.05; 
 TC = total cholesterol, TG= triglycerides, HDL= high density lipoprotein, LDL= low density lipoprotein,  
ME= methanolic extract 
Keys: 
a= significantly higher compared to normal control  
b= significantly lower compared to diabetic control  
c= significantly higher compared to diabetic control   
d= significantly lower compared to standard control 
 
DISCUSSION: 
Oxidative stress (imbalance between the pro-
oxidants and antioxidant defense system of the 
body as a result of steady state reactive oxygen 
species (ROS)) has been shown to be responsible 
for damage to biomolecules [30,31], at least in part 
for pancreatic β-cell dysfunction caused by glucose 
toxicity in hyperglycaemia. During these processes, 
ROS are produced and cause tissue damage 
[32,33]. Therefore, the radical scavenging activity 
and reducing power of   Phyllanthus fraternus 
observed in this study can help in tackling tissue 
damage and onward complications associated with 
diabetes mellitus [8].This scavenging activity and 
reducing power is associated with the presence of 
phenols and flavonoids in the plants which have 
been previously reported to be responsible for 
various antioxidant activites[34].  
Furthermore, prolonged treatment (28 days) with 
methanolic extract of phyllanthus fraternus (MEP) 
(200 & 300 mg/kg body weight) and metformin 
(5mg/kg b.w) showed continual decrease of blood 
glucose, suggesting long term maintenance of 
blood glucose level in diabetic rats. Several 
medicinal plants have been reported to restore 
activity of key enzymes of glucose and glycogen 
metabolism which are strongly disturbed in 
streptozotocin diabetic rats [35,36]. Hypoglycaemic 
effect of MEP may arise from the inhibition of 
hepatic glucose production, or insulin signalling 
[37]. 
 
Diabetic untreated rats showed increased plasma 
lipids which is the major risk factor for different 
cardiovascular diseases associated with diabetes 
mellitus [38]. An increased level of serum 
cholesterol indicates hypercholesterolemia, 
hyperlipidemia, hypothyroidism, uncontrolled 
diabetes, and nephritic syndrome and cirrhosis. 
This high serum lipid is due to increase in the 
mobilization of free fatty acids from the peripheral 
fat depots and due to lipolysis caused by lipolytic 
hormones[39]. The present study showed increase 
in total cholesterol (TC), triglycerides (TG), and 
low density lipoprotein (LDL) in the diabetic 
untreated group with decreased level of high 
density lipoprotein HDL. Treatment with MEP 
showed significant reduction of the 
hyperlipidaemia observed which may be due to the 
control of blood glucose level and thereby control 
of the lipolytic hormones[38]. 
: 
REFERENCES: 
1.World Health Organization (2014).  "Diabetes 
Programme". Retrieved 22 April 2014. 
2.Hayat SA, Siddiqui MS, and Shaikh N. Updates in 
the management of cutaneous manifestations of 
diabetes mellitus. World Appl. Sci. J. 2010,8:394-399. 
3.World Health Organization. (2013)."The top 10 
causes of death Fact sheet No.310" 
4.Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. 
Hyperglyacaemic crises in adult patients with 
diabetes. Diabetes Care, 2009; 32 (7): 1335–1343.  
5.Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., 
Michaud, C., Ezzati, M., Shibuya, K. et al. "Years 
lived with disability (YLDs) for 1160 sequelae of 289 
diseases and injuries 1990–2010: a systematic analysis 
for the Global Burden of Disease Study 
2010.” Lancet, 2012;380: (9859), 2163–2196. 
6.International Diabetes Federation. (IDF) (2014). 
Estimated Healthcare expenditures due to diabetes in 
the North America and Caribbean . " Diabetes Atlas 
Update". 
7.International Diabetes Federation (IDF) (2013). IDF 
Diabetes Atlas (6th ed). pp 7. 
8.Rahimi, R., Nikfar, S., Larijani, B., and Abdollahi, 
M. A review on the role of antioxidants in the 
management of diabetes and its complications. 
Biomedicine & Pharmacotherapy, 2005;59 (7): 365-
373. 
9.Sargeant, L. A., Wareham, N. J., Bingham, S., Day, 
N. E., Luben, R. N., Oakes, S., et al., Vitamin C and 
hyperglycemia in the European prospective 
investigation into cancer - norfolk (EPIC-norfolk) 
study - A population-based study. Diabetes 
Care,2000; 23 (6): 726-732. 
10.Song, Y., Cook, N., Albert, C., Denburgh, M. V., 
& Manson, J. E. Effects of vitamins C and E and beta-
carotene on the risk of type 2 diabetes in women at 
high risk of cardiovascular disease: A randomized 
IAJPS 2017, 4 (01), 103-109             Nadro, M.S and Elkanah, G.          ISSN 2349-7750 
 
w w w . i a j p s . c o m  
 
Page 7 
controlled trial. The American Journal of Clinical 
Nutrition, 2009;90 (2): 429-437. 
11.Mullan, B. A., Young, I. S., Fee, H., and McCance, 
D. R. (2002). Ascorbic acid reduces blood pressure 
and arterial stiffness in type 2 diabetes. Hypertension, 
40: (6), 804-809. 
12.Regensteiner, J. G., Popylisen, S., Bauer, T. A., 
Lindenfeld, J., Gill, E., Smith, S., et al., Oral L-
arginine and vitamins E and C improve endothelial 
function in women with type 2 diabetes. Vascular 
Medicine, 2003;8 (3): 169-175. 
13.Matur,B.M., Mathew, T. and Ifeanyi C.I.C. 
Analysis of the phytochemical and invivo antimalaria 
properties of Phyllanthus fraternus Webster extract. 
New York Science Journal, 2009;2(5), 12-13.  
14.The wealth of India, (1995). A Dictionary of 
Indian Raw Material and Industrial Products. 
Publication and Information Directorate. CSIR, New 
Delhi, 8: 34-35. 
15.Calixto JB, Santos ARS, Filho VC and Yunes  RA. 
A review of the plants of the genus Phyllanthus: Their 
chemistry, pharmacology and therapeutic potential. 
Med. Res. Rev. 1998;18. 225-258. 
16.Ramkrishnan, P. N., Murgesan, R, Palanichamy, S. 
and Murgesh, N.,Oral hypoglycaemic effect of 
Phyllanthus niruri (Linn) leaves. Indian journal of 
Pharmaceutical Studies,1982;p 44: 10-12. 
17.Ahmed, B., A1-Howiriny T. A. and Mathew R., 
Antihepatotoic activity of Phyllanthus fraternus. 
pharmazie,2002; 57: 855-856. 
18.Ugwu, M.N., Umar, I.A, Ibrahim, S. and Ibrahim, 
M.A. Hypoglycaemic and Hypolipidaemic activity of 
solvent extracts of Ocimum basilicum leaves in 
Strptozotocin-induced diabetic rats. Nigerian Journal 
of Biochemistry and Molecular Biology, 2011;26 (2): 
126-134. 
19.Koleva, I. I., Van Beek, T. A., Linssen, J. P., 
Groot, A. D. and Evstatieva, L. N. Screening of plant 
extracts for antioxidant activity: a comparative study 
on three testing methods. Phytochemical 
Analysis,2002; 13: 8-17. 
20.Lee, S. E, Hwang, H. J. and Ha, J. S. Screening of 
Medicinal Plant Extracts or Antioxidant Activity. Life 
Science,2003;s 73: 167-179. 
21.Naznin, A. and Hasan, N. In vitro Antioxidant 
Activity of Methanolic Leaves and Flowers Extracts 
of Lippia Alba. Research Journal of Medicine and 
Medical Sciences,2009; 4 (1): 107-110.  
22.Banerjee, D., Chakrabarti, S., Hazra, A. K., 
Banerjee, S., Ray, J. and Mukherjee, B. Antioxidant 
Activity and Total Phenolics of Some Mangroves in 
Undarbans. African Journal of Biotechnology ,2008;7. 
805–810. 
23.Al-Hariri MT, Gamal EB, Abu-Hozaifa and Elnour 
A . Glycemic control and anti-Osteopathic Effect of 
Propolis in diabetic Rats. Diabetes, metabolic 
syndrome and obesity, 2011;4: 377-384 
24.Barry JAA, Hassan IAA and Al-Hakiem MHH. 
Hypoglycemic and Antihyperglycemic effect of 
Trigonella foenum-graecum leaf in normal and 
alloxan induced diabetic rats. J.  
Ethnopharmacol,1997; 58: 149-154. 
25.Akbarazadeh A, Norouzian D, Jamshidi SH, 
Farhangi A, AllaVerdia A, Motidan SMA et al.,  Ind. 
J. Clin. Bioc2007;, 22: 64-69. 
26.Parthasarthy, R. S. and IIavarasan, R. Antidiabetic 
activity of Thespesia populnea bark and leaf extract 
against streptozotocin induced diabetic rats. 
International journal of Pharmatech research, 
2009;4: 1069-1072. 
27.Allain, C. C., Poon, L. S., Chan, C. S., Richmond, 
W., Fu, P. C. Enzymatic Determination of Total 
Serum Cholesterol.  Journal of Clinical Chemistry, 
1974;20: 470. 
28.Jacobs, N. And VanDemark, P. J. Methods in 
Enzymology. Archives of Biochemistry and 
Biophysics, 1960;88: 250-255. 
29.Duncan, R.C., Knapp, R.G., Miller, M.C. (1977). 
Test of hypothesis in population means. Introductory 
biostatistics for health sciences. John Wiley and sons 
Inc. NY: 71-96. 
30.Jorgensen, L.V., Madsen, H. L., Thomsen, M. K., 
Dragsted, L. O., Skibsted, L. H. (1999). Regulation of 
phenolic antioxidants from phenoxyl radicals: An 
ESR and electrochemical study of antioxidant 
hierarchy. Free Radical Research, 30: 207-220. 
31.Halliwell, B.,  Zhao, K., Whiteman,  M. (1999). 
Nitric oxide and peroxynitrite: the ugly, the uglier and 
the not so good: a personal view of recent 
controversies. Free Radical Research, 31: 651–669. 
32.Hunt, J. V., Smith, C. C., Wolf, S. P.(1990). Auto-
oxidative glycosylation and possible involvement of 
peroxides and free radicals in LDL Modification by 
glucose. Diabetes, 39:1420-1424. 
33.Matsuoka, T., kajimoto, Y., Watada, H.,kaneto, H., 
Kishmoto, M., Umayahara, Y. et al., Glycation- 
dependent reactive oxygen species-mediated 
suppression of the insulin gene promoter activity in 
HIT cells. Journal of critical investigation, 1998;99: 
144-150. 
34.Sutharsingh, R., Kavimani, S., Jayakar, B., 
Uvarani,  M., Thangathirupathi, A. Quantitative 
Phytochemical Estimation and Antioxidants Studies 
on Aerial Parts of Naravelia zeylanica DC. 
International journal of pharmaceutical studies and 
research, 2011;2 (2), 52-56 
35.Eddouks M, Jouad H, Maghrani M, Lemhadri A, 
Burcelin R (2003). Inhibition of endogenous glucose 
production accounts for hypoglycaemic effect of 
Spergularia purpurea in diabetic mice. 
Phytomedicine, 10: 594–599. 
36.Sharma, B., Salunke, R., Balomajumder, C., 
Daniel, S. and Roy, P. Anti-diabetic Potential of 
Alkaloid Rich Fraction from Capparis Decidua on 
Diabetic Mice,” Journal of Ethnopharmacology, 
2010;127 (2): 457- 462 
37.Qin, B., Nagasaki, M., Ren, M., Bajotto, G., 
Oshida, Y. and Sato, Y. Cinnamon Extract 
(Traditional Herb) Potentiates in vivo Insulin-
Regulated Glucose Utilization Via Enhancing Insulin 
Signaling in Rats. Diabetes Research and Clinical 
Practice, 2003;62: (3), 139–148. 
38.Garg M, Garg C, Dhar VJ and Kalia AN. 
Standardized alcoholic extract of Phyllanthus 
fraternus exerts potential action against disturbed 
biochemical parameters in diabetic animals. Afri. J. 
Bioc. Res.200; 4 (7): 188-190.  
39.Murray, R.K., Granner, D.K., Mayes, P.A., 
Rowell, V.W. (2000). Harpers Biochemistry, (25th 
ed.). Stanford CT, Appleton and Lange: pp 610-617. 
